194 results on '"Brust, James C. M."'
Search Results
2. Pre-detection history of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa
3. Drug-Resistant Tuberculosis and HIV
4. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
5. Spatial Patterns of Extensively Drug-Resistant Tuberculosis Transmission in KwaZulu-Natal, South Africa
6. Management of active tuberculosis in adults with HIV
7. Genotype–Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
8. Genotype–Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis
9. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis–Human Immunodeficiency Virus Coinfection in South Africa
10. “Weighting” the Evidence: How Much Bedaquiline Is Enough?
11. Model-Predicted Impact of ECG Monitoring Strategies During Bedaquiline Treatment
12. Reply to Seddon, Schaaf, and Hesseling
13. Model-Predicted Impact of ECG Monitoring Strategies During Bedaquiline Treatment
14. Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa
15. Optimized Loading Dose Strategies for Bedaquiline When Restarting Interrupted Drug-Resistant Tuberculosis Treatment
16. Old Drugs, New Purpose: Retooling Existing Drugs for Optimized Treatment of Resistant Tuberculosis
17. Adherence Measured Using Electronic Dose Monitoring is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant Tuberculosis
18. Optimized Loading Dose Strategies for Bedaquiline When Restarting Interrupted Drug-Resistant Tuberculosis Treatment
19. Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study
20. Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa
21. Linezolid Population Pharmacokinetics in South African Adults with Drug-Resistant Tuberculosis
22. Relationship between Plasma and Intracellular Concentrations of Bedaquiline and Its M2 Metabolite in South African Patients with Rifampin-Resistant Tuberculosis
23. TCA cycle remodeling drives proinflammatory signaling in humans with pulmonary tuberculosis
24. Evidence-based Definition for Extensively Drug-Resistant Tuberculosis
25. Model-Predicted Impact of ECG Monitoring Strategies During Bedaquiline Treatment.
26. Relationship between Plasma and Intracellular Concentrations of Bedaquiline and Its M2 Metabolite in South African Patients with Rifampin-Resistant Tuberculosis
27. Effect of delayed diagnosis on severity of Pott’s disease
28. Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study
29. Clofazimine pharmacokinetics in patients with TB : dosing implications
30. TB/HIV: An Orphan Disease?
31. Clofazimine pharmacokinetics in patients with TB: dosing implications
32. Modeling Missing Cases and Transmission Links in Networks of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa
33. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
34. Five cases of bacteraemia due to Gordonia species
35. Social Mixing and Clinical Features Linked With Transmission in a Network of Extensively Drug-resistant Tuberculosis Cases in KwaZulu-Natal, South Africa
36. Linezolid Pharmacokinetics in South African Patients with Drug-Resistant Tuberculosis and a High Prevalence of HIV Coinfection
37. rpoB Mutations Causing Discordant Rifampicin Susceptibility in Mycobacterium tuberculosis: Retrospective Analysis of Prevalence, Phenotypic, Genotypic, and Treatment Outcomes
38. Social Mixing and Clinical Features Linked With Transmission in a Network of Extensively Drug-resistant Tuberculosis Cases in KwaZulu-Natal, South Africa.
39. The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events.
40. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
41. MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care
42. Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis–Human Immunodeficiency Virus Coinfection in South Africa
43. Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South Africa
44. Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South Africa
45. European Respiratory Monograph: Tuberculosis. Vol 58 Christoph Lange Giovanni Battista Migliori
46. Dilemma of managing asymptomatic children referred with ‘culture-confirmed’ drug-resistant tuberculosis
47. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa
48. Incidence and Geographic Distribution of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal Province, South Africa
49. pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.
50. Association between Health Systems Performance and Treatment Outcomes in Patients Co-Infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: Implications for TB Programmes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.